Boris Labar
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
-
- Lymphoma Diagnosis and Treatment
Papers in
- Hematology 119
- Hematopoietic Stem Cell Transplantation 60
- Acute Myeloid Leukemia Research 50
- Chronic Myeloid Leukemia Treatments 11
- Multiple Myeloma Research and Treatments 8
-
- Lymphoma Diagnosis and Treatment 19
- Co-authors
- Stefan Suciu (20 shared papers)Petra Muus (16 shared papers)Theo J.M. de Witte (11 shared papers)Mirando Mršić (28 shared papers)Igor Aurer (26 shared papers)Ivo Radman (27 shared papers)Liliana Baila (3 shared papers)Dominik Selleslag (8 shared papers)
- Journals
- Blood (21 papers)Annals of Hematology (10 papers)Haematologica (5 papers)Bone Marrow Transplantation (5 papers)Leukemia (3 papers)
- Partner nations
- CroatiaNetherlandsItaly
In The Last Decade
Boris Labar
150 papers receiving 3.4k citations
Boris Labar's Hit Papers
Peers
Comparison fields: 5 of 99
- Hematology 2.5k
- Pathology and Forensic Medicine 187
- Genetics 95
- Oncology 160
- Clinical Biochemistry 34
Countries citing papers authored by Boris Labar
This map shows the geographic impact of Boris Labar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Labar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Labar more than expected).
Fields of papers citing papers by Boris Labar
This network shows the impact of papers produced by Boris Labar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Labar. The network helps show where Boris Labar may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Labar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia Hit paper breakdown → | 1995 | 694 |
| 2 | Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group Hit paper breakdown → | 2011 | 475 |
| 3 | 2008 | 175 | |
| 4 | 2009 | 157 | |
| 5 | 2013 | 147 | |
| 6 | 2015 | 77 | |
| 7 | Relationship between differing volumes of bone marrow aspirates and their cellular composition. | 1990 | 73 |
| 8 | Prostaglandin E2 for prophylaxis of oral mucositis following BMT. | 1993 | 71 |
| 9 | Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients | 2004 | 67 |
| 10 | 2020 | 59 | |
| 11 | 2008 | 58 | |
| 12 | Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups. | 1996 | 57 |
| 13 | 2002 | 50 | |
| 14 | 2008 | 49 | |
| 15 | 2007 | 48 | |
| 16 | Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation. | 1989 | 46 |
| 17 | 2011 | 41 | |
| 18 | 2008 | 40 | |
| 19 | 2018 | 38 | |
| 20 | 2003 | 37 |
About Boris Labar
Boris Labar is a scholar working on Hematology, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health, Genetics and Oncology, having authored 160 papers that have together received 3.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (60 papers), Acute Myeloid Leukemia Research (50 papers), Lymphoma Diagnosis and Treatment (19 papers), Acute Lymphoblastic Leukemia research (11 papers), Chronic Myeloid Leukemia Treatments (11 papers), Multiple Myeloma Research and Treatments (8 papers), Global Cancer Incidence and Screening (2 papers) and Clinical Laboratory Practices and Quality Control (2 papers). The work is most often cited by research in Hematology (2.5k citations), Pathology and Forensic Medicine (187 citations), Genetics (95 citations), Oncology (160 citations) and Clinical Biochemistry (34 citations). Boris Labar has collaborated with scholars based in Croatia, Netherlands and Italy. Frequent co-authors include Stefan Suciu, Petra Muus, Theo J.M. de Witte, Mirando Mršić, Igor Aurer, Ivo Radman, Liliana Baila, Dominik Selleslag, P. Wijermans and Filip Beeldens. Their work appears in journals such as Blood, Annals of Hematology, Haematologica, Bone Marrow Transplantation and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.